LEADER 00975nam0-2200289---450-
001 990009364140403321
005 20110520101704.0
010   $a92-824-3192-4
035   $a000936414
035   $aFED01000936414
035   $a(Aleph)000936414FED01
035   $a000936414
100   $a20110520d2006----km-y0itay50------ba
101 0 $aita
102   $aLU
105   $a--------001yy
200 1 $aVersioni consolidale del trattato sull'unione europea e del trattato che istituisce la Comuinità europea$fUnione europea
210   $aLussemburgo$cUfficio delle pubblicazioni ufficiali delle Comunità europee$d2006
215   $a331 p.$d25 cm
710 02$aUnione europea$0361259
801  0$aIT$bUNINA$gRICA$2UNIMARC
901   $aBK
912   $a990009364140403321
952   $a62 0610.CE 4$b10668$fDAGEA
959   $aDAGEA
996   $aVersioni consolidale del trattato sull'unione europea e del trattato che istituisce la Comuinità europea$9762677
997   $aUNINA

LEADER 01866nam  2200373   450 
001 9910688581803321
005 20230623125816.0
035   $a(CKB)5400000000040666
035   $a(NjHacI)995400000000040666
035   $a(EXLCZ)995400000000040666
100   $a20230623d2020      uy             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aLupus $enew advances and challenges /$fedited by Sophia Lionaki
210  1$aLondon, England :$cIntechOpen,$d2020.
215   $a1 online resource (138 pages)
311   $a1-83880-184-7 
330   $aSystemic lupus erythematosus, the prototype of an autoimmune disorder, may affect several organs and may run a chronic course between relapse and remission. This book covers important aspects of the disease, including epidemiology, pathophysiology, and neuropsychiatric manifestations, including basic science and clinical features and management. In affected patients, the fundamental problem of fertility is reassessed including the risk of the disease, the possibility of fetal loss, the safety of drugs during pregnancy, and the current diagnostic and suggested therapeutic strategies of reproductive medicine. Finally, the issue of pathogenesis is revisited with a thorough description of animal models in relation to physiology and potential novel therapies.
517   $aLupus 
606   $aSystemic lupus erythematosus$vPopular works
606   $aSystemic lupus erythematosus$xAlternative treatment
615  0$aSystemic lupus erythematosus
615  0$aSystemic lupus erythematosus$xAlternative treatment.
676   $a616.77
702   $aLionaki$b Sophia
801  0$bNjHacI
801  1$bNjHacl
906   $aBOOK
912   $a9910688581803321
996   $aLupus$91927242
997   $aUNINA